ArticleCombinatorial chemistry & high throughput screening2026
Studies Combining Network Pharmacology with
Article in Combinatorial chemistry & high throughput screening, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
introductionThe objective of this investigation was to examine the mechanism through which Radix isatidis operates, utilizing network pharmacology and molecular docking techniques.
methodsA Protein-Protein Interaction (PPI) network connecting the targets of the active ingredients with those related to febrile diseases was constructed through STRING. The analysis of the core nodes was conducted using the Cytoscape software, followed by further exploring the PPI network using the DAVID database. Lastly, the underlying mechanism of the antipyretic action was also examined utilizing the DAVID database. Mice were injected intraperitoneally with lipopolysaccharides (LPS) and treated by continuous gavage with Radix isatidis. The mice were then evaluated using temperature monitoring, blood tests, organ index calculations, PI3K-AKT pathway protein assays, and reverse transcription polymerase chain reaction (RT-PCR) assays for inflammatory factors.
resultsTwelve active components of Radix isatidis were screened, and 107 genes were identified at the intersection of Radix isatidis and fever. These genes were found to be involved in the PI3K-AKT signaling pathway, proteoglycans in cancer, and mechanisms related to blood lipids and atherosclerosis. The top nine targets identified by constructing a PPI network were IL6, AKT1, EGFR, STAT3, CASP3, ESR1, PTGS2, PPARG, and MAPK3, indicating that Radix isatidis may play a protective role by affecting the PI3K/AKT-related signaling pathway. DISCUSSION: In the in vitro experimental validation, a fever model was established using LPS, while Radix isatidis was used for treatment, and the PI3K/AKT/NF-κB pathway was validated by temperature monitoring, observation of pathological tissue sections, western blotting, immunohistochemistry, RT-PCR, and other technical means. In vivo experiments were conducted to verify the method in multiple mediums, and both the genetic changes and related pathway proteins are consistent with the KEGG prediction.
conclusionThe PI3K/AKT pathway was identified through PPI network analysis, key target identification, and KEGG pathway enrichment. Subsequent in vivo studies in mice confirmed that Radix isatidis could alleviate inflammation and body fever caused by LPS by affecting the PI3K/AKT pathway.
Indexed as
Identifiers
40539351What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.